Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy

Journal of Urology

Volumn 196, Issue 5, 2016, Pages 1408-1414

  Leapman, Michael S ^a   Freedland, Stephen J ^c   Aronson, William J ^d   Kane, Christopher J ^e   Terris, Martha K ^f   Walker, Kelly ^a   Amling, Christopher L ^g   Carroll, Peter R ^a   Cooperberg, Matthew R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

African Americans; neoplasm grading; neoplasm staging; prostatic neoplasms; watchful waiting

Indexed keywords

ADULT; ADVERSE OUTCOME; AFRICAN AMERICAN; ARTICLE; BIOCHEMICAL RECURRENCE; CANCER STAGING; CAUCASIAN; COHORT ANALYSIS; HISTOPATHOLOGY; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; BLOOD; COMPARATIVE STUDY; FACTUAL DATABASE; PATHOLOGY; PROSTATE TUMOR; RISK ASSESSMENT; UNITED STATES; WATCHFUL WAITING;

PROSTATE SPECIFIC ANTIGEN;

AFRICAN AMERICANS; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES; WATCHFUL WAITING;

EID: 84992341733     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2016.06.086     Document Type: Article

References (30)

1. 1 Faisal, F.A., Sundi, D., Cooper, J.L., et al. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up. Urology, 84, 2014, 1434.
2. 2 Klotz, L., Vesprini, D., Sethukavalan, P., et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol, 33, 2015, 272.
3. 3 Tsivian, M., Banez, L.L., Keto, C.J., et al. African-American men with low grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center. Prostate Cancer Prostatic Dis, 16, 2013, 91.
4. 4 Ritch, C.R., Morrison, B.F., Hruby, G., et al. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison. BJU Int, 111, 2013, E186.
5. 5 Chu, K.C., Tarone, R.E., Freeman, H.P., Trends in prostate cancer mortality among black men and white men in the United States. Cancer, 97, 2003, 1507.
6. 6 Du, X.L., Fang, S., Coker, A.L., et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer, 106, 2006, 1276.
7. 7 Gaines, A.R., Turner, E.L., Moorman, P.G., et al. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort. Cancer Causes Control, 25, 2014, 1029.
8. 8 Iremashvili, V., Soloway, M.S., Rosenberg, D.L., et al. Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance. J Urol, 187, 2012, 1594.
9. 9 Abern, M.R., Bassett, M.R., Tsivian, M., et al. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center. Prostate Cancer Prostatic Dis, 16, 2013, 85.
10. 10 Odom, B.D., Mir, M.C., Hughes, S., et al. Active surveillance for low-risk prostate cancer in African American men: a multi-institutional experience. Urology, 83, 2014, 364.
11. 11 Sundi, D., Faisal, F.A., Trock, B.J., et al. Reclassification rates are higher among African American men than Caucasians on active surveillance. Urology, 85, 2015, 155.
12. 12 Sundi, D., Ross, A.E., Humphreys, E.B., et al. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?. J Clin Oncol, 31, 2013, 2991.
13. 13 Ha, Y.S., Salmasi, A., Karellas, M., et al. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance. Urology, 81, 2013, 831.
14. 14 Jalloh, M., Myers, F., Cowan, J.E., et al. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Eur Urol, 67, 2015, 451.
15. 15 Weiner, A.B., Patel, S.G., Eggener, S.E., Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States. Urol Oncol, 33, 2015, 164.e11.
16. 16 Moreira, D.M., Nickel, J.C., Andriole, G.L., et al. Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study. Prostate Cancer Prostatic Dis, 19, 2016, 180.
17. 17 Freedland, S.J., Amling, C.L., Dorey, F., et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology, 60, 2002, 670.
18. 18 Punnen, S., Freedland, S.J., Presti, J.C. Jr., et al. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol, 65, 2014, 1171.
19. 19 Carter, H.B., Kettermann, A., Warlick, C., et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol, 178, 2007, 2359.
20. 20 Dall'Era, M.A., Konety, B.R., Cowan, J.E., et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer, 112, 2008, 2664.
21. 21 Sajadi, K.P., Terris, M.K., Hamilton, R.J., et al. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. J Urol, 178, 2007, 990.
22. 22 Sundi, D., Kryvenko, O.N., Carter, H.B., et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol, 191, 2014, 60.
23. 23 Witte, M.N., Kattan, M.W., Albani, J., Race is not an independent predictor of positive surgical margins after radical prostatectomy. Urology, 54, 1999, 869.
24. 24 Jayachandran, J., Aronson, W.J., Terris, M.K., et al. Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. BJU Int, 102, 2008, 964.
25. 25 Tewari, A., Sooriakumaran, P., Bloch, D.A., et al. Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol, 62, 2012, 1.
26. 26 von Bodman, C., Matikainen, M.P., Yunis, L.H., et al. Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy. Urology, 76, 2010, 1092.
27. 27 Allott, E.H., Howard, L.E., Song, H.J., et al. Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy. Cancer Epidemiol Biomarkers Prev, 23, 2014, 2404.
28. 28 Yamoah, K., Deville, C., Vapiwala, N., et al. African American men with low grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol, 33, 2015, 70.e15.
29. 29 Kane, C.J., Im, R., Amling, C.L., et al. Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. Urology, 76, 2010, 695.
30. 30 Hamilton, R.J., Aronson, W.J., Presti, J.C. Jr., et al. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer, 110, 2007, 2202.